Latest News
Via The Motley Fool · May 12, 2025
Costs could fall, revenues could rise, and nuclear power profits could explode -- in a good way, not a Chernobyl way.
Via The Motley Fool · May 12, 2025
Stocks are soaring today on the hope that the trade tensions between the U.S. and China are behind us.
Via The Motley Fool · May 12, 2025
Via The Motley Fool · May 12, 2025
Tech stocks rally as the U.S. announces a China trade deal in Geneva.
Via The Motley Fool · May 12, 2025
Via The Motley Fool · May 12, 2025
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Monday. Stay informed about the latest market trends.
Via Chartmill · May 12, 2025
Via Benzinga · May 12, 2025
A review of the recent price action in the e-mini SP500 futures contract.
Via Talk Markets · May 12, 2025
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
Via Chartmill · May 12, 2025
Shares of Marvell Technology jumped 7.7% during Monday's trading session. The move higher was driven by investor optimism following a breakthrough in U.S.-China trade negotiations.
Via Benzinga · May 12, 2025
Analysts see 42% upside potential with a Buy rating and $11.10 target. Technicals also show a strong uptrend.
Via Benzinga · May 12, 2025
Bilibili surged 6.5% Monday morning. The stock gained following a breakthrough in U.S.–China trade relations.
Via Benzinga · May 12, 2025
Shares of Chinese internet and gaming giant NetEase rose 4.2% Monday morning. The stock gained following news that the US and China had agreed to a temporary easing of tariffs.
Via Benzinga · May 12, 2025
The beverage stock has been great, awful, and great. It just depends on where you draw the starting line.
Via The Motley Fool · May 12, 2025
Via Benzinga · May 12, 2025
As Wall Street rallies on the US-China trade truce, April inflation data may cool Fed cut hopes if price pressures persist.
Via Benzinga · May 12, 2025
The U.S. President said that Big Pharma would either voluntarily abide by this principle or the federal government will use its power to ensure the U.S. pays the same price as other countries.
Via Stocktwits · May 12, 2025